Element Capital Management LLC Innoviva, Inc. Transaction History

Element Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $300,828 - $343,311	-22,964 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$13.69 - $20.06 $87,848 - $128,725	6,417 Added 38.78%	22,964 $322,000
Q4 2018 Feb 13, 2019	SELL	$13.96 - $18.26 $288,287 - $377,087	-20,651 Reduced 55.52%	16,547 $289,000
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $234,313 - $269,898	17,191 Added 85.92%	37,198 $567,000
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $3,494 - $4,573	-260 Reduced 1.28%	20,007 $276,000
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $279,684 - $344,336	20,267 New	20,267 $338,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.